RXST Q4 2022 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$16M+90.9% YoY

Gross Profit

$7M46.1% margin

Operating Income

-$15M-93.2% margin

Net Income

-$16M-97.0% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

+27.5%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$150M

Total Liabilities

$60M

Stockholders' Equity

$90M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$8M	+90.9%
Gross Profit	$7M	$3M	+158.7%
Operating Income	-$15M	-$15M	-2.2%
Net Income	-$16M	-$16M	+0.8%